ConductScience.org, home

Paper22367451

Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.

Arthur JR and 3 others. Neurochem Res, 2012. Cited by 16 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice. Papers, record 22367451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22367451

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
PubMed
Journal
Neurochem Res
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2021-10-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arthur JRJ R
2Lee JPJ P
3Snyder EYE Y
4Seyfried TNT N

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
1-DeoxynojirimycinMajor topic
Neural Stem CellsMajor topic
Sandhoff DiseaseMajor topic
Animals
G(M2) Ganglioside
Hexosaminidase B
Mice
beta-N-Acetylhexosaminidases

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116371952Gene therapy: can neural stem cells deliver?Nat Rev Neurosci2006https://conductscience.org/library/papers/16371952PubMed
2395887Early diagnosis and prevention of genetic disease.Ann Clin Biochem1979https://conductscience.org/library/papers/395887PubMed
318387328Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.Mol Genet Metab2008https://conductscience.org/library/papers/18387328PubMed
417351625Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.Nat Med2007https://conductscience.org/library/papers/17351625PubMed
510339597Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10339597PubMed
67550345Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.Nat Genet1995https://conductscience.org/library/papers/7550345PubMed
719898952Substrate deprivation therapy in juvenile Sandhoff disease.J Inherit Metab Dis2009https://conductscience.org/library/papers/19898952PubMed
810718340N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.Biochem Pharmacol2000https://conductscience.org/library/papers/10718340PubMed
96875549Cellular localization of gangliosides in the developing mouse cerebellum: analysis using the weaver mutant.J Neurochem1983https://conductscience.org/library/papers/6875549PubMed
1015687347Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.J Lipid Res2005https://conductscience.org/library/papers/15687347PubMed
111159420Gangliosides in developing mouse brain myelin.J Neurochem1975https://conductscience.org/library/papers/1159420PubMed
121732063Multipotent neural cell lines can engraft and participate in development of mouse cerebellum.Cell1992https://conductscience.org/library/papers/1732063PubMed
138993691Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system.Adv Neurol1997https://conductscience.org/library/papers/8993691PubMed
149695839Glucosylceramide synthase and glycosphingolipid synthesis.Trends Cell Biol1998https://conductscience.org/library/papers/9695839PubMed
15670832Isolation and characterization of human liver hematoside.J Lipid Res1978https://conductscience.org/library/papers/670832PubMed
1610359833"Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10359833PubMed
1716400817New developments in treating glycosphingolipid storage diseases.Adv Exp Med Biol2005https://conductscience.org/library/papers/16400817PubMed
187885477Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.Nature1995https://conductscience.org/library/papers/7885477PubMed
1918341399Cellular therapy for childhood neurodegenerative disease. Part I: rationale and preclinical studies.Neurosurg Focus2008https://conductscience.org/library/papers/18341399PubMed
2011070094Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/11070094PubMed

See all 52 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42738833Application of Mesenchymal Stromal Cells and Their Exosomes in Neurodegenerative Diseases and Lysosomal Storage Diseases.Cells2026https://conductscience.org/library/papers/42738833PubMed
40866328Microglial replacement in a Sandhoff disease mouse model reveals myeloid-derived β-hexosaminidase is necessary for neuronal health.Nat Commun2025https://conductscience.org/library/papers/40866328PubMed
39484433Myeloid-derived β-hexosaminidase is essential for neuronal health and lysosome function: implications for Sandhoff disease.bioRxiv2024https://conductscience.org/library/papers/39484433PubMed
37488869Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells.Neural Regen Res2024https://conductscience.org/library/papers/37488869PubMed
35434178Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.Mol Ther Methods Clin Dev2022https://conductscience.org/library/papers/35434178PubMed
32592687Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice.Mol Ther2020https://conductscience.org/library/papers/32592687PubMed
31208914Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity.Mol Ther2019https://conductscience.org/library/papers/31208914PubMed
27499644Animal models of GM2 gangliosidosis: utility and limitations.Appl Clin Genet2016https://conductscience.org/library/papers/27499644PubMed
27420186Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases.Hum Gene Ther2016https://conductscience.org/library/papers/27420186PubMed
27083890Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.Orphanet J Rare Dis2016https://conductscience.org/library/papers/27083890PubMed
25474439Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.Gene Ther2015https://conductscience.org/library/papers/25474439PubMed
25206577Two outward potassium current types are expressed during the neural differentiation of neural stem cells.Neural Regen Res2013https://conductscience.org/library/papers/25206577PubMed
23417430Ethylenedioxy-PIP2 oxalate reduces ganglioside storage in juvenile Sandhoff disease mice.Neurochem Res2013https://conductscience.org/library/papers/23417430PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22367451

GET https://conductscience.org/api/papers/v1/22367451/references?page=2